Evidence, ethics and medication management in older people

Journal of Pharmacy Practice and Research

Volumn 40, Issue 2, 2010, Pages 148-152

  Le Couteur, David G ^a   Ford, Gary A ^b   McLachlan, Andrew J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE; NEBIVOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; SPIRONOLACTONE; WARFARIN;

BLEEDING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FRAIL ELDERLY; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL ETHICS; POLYPHARMACY; RESOURCE ALLOCATION; REVIEW; RISK BENEFIT ANALYSIS; STROKE; TREATMENT PLANNING;

EID: 77954885820     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2010.tb00523.x     Document Type: Review

References (51)

1. Roughead EE, Anderson B, Gilbert AL. Potentially inappropriate prescribing among Australian veterans and war widows/widowers. Intern Med J 2007;37:402-5.
2. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007;21:217-30.
3. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-84.
4. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996;312:71-2.
5. Rochat S, Cumming R G, Blyth F, Creasey H, Handelsman D, Le Couteur D G, et al. Frailty and use of health and community services by community-dwelling older men: the Concord Health and Ageing in Men Project. Age Ageing 2010;39:228-33.
6. Fisher AA, McLean AJ, Davis MW, Le Couteur DG. A multicenter, case-control study of the effects of antihypertensive therapy on orthostatic hypotension, postprandial hypotension, and falls in octo-and nonagenarians in residential care facilities. Curr Ther Res Clin Exp 2003;64:206-14.
7. Gnjidic D, Cumming R G, Le Couteur DG, Handelsman DJ, Naganathan V, Abernethy DR, et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol 2009;68:97-105.
8. Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008;64:183-99.
9. Abernethy DR. Research challenges, new drug development, preclinical and clinical trials in the ageing population. Drug Saf 1990;5(suppl):S71-S74.
10. Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ 2000;320:1036.
11. Roughead EE, Gilbert AL, Primrose J G, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1997;168:405-8.
12. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
13. Williams JR, editor. The World Medical Association medical ethics manual. Ferney-Voltaire Cedex: The World Medical Association; 2005.
14. Gillon R. Ethics needs principles - four can encompass the rest-and respect for autonomy should be first among equals. J Med Ethics 2003;29:307-12.
15. Le Couteur DG, Hilmer SN, Glasgow N, Naganathan V, Cumming RG. Prescribing in older people. Aust Fam Physician 2004;33:777-81.
16. Le Couteur D G, Kendig H, Naganathan V, McLachlan AJ. The ethics of prescribing medications in older people. In: Koch S, Gloth FM, Nay R, editors. Handbook of medication management in older adults. Humana Press. In press.
17. Le Couteur D G, Kendig H. Pharmaco-epistemology for the prescribing geriatrician. Australas J Ageing 2008;27:3-7.
18. Ridda I, MacIntyre CR, Lindley RI, Tan TC. Difficulties in recruiting older people in clinical trials: an examination of barriers and solutions. Vaccine 2010;28:901-6.
19. Nair BR. Evidence based medicine for older people: available, accessible, acceptable, adaptable? Australas J Ageing 2002;21:58-60.
20. Jennens RR, Giles G G, Fox RM. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials. Intern Med J 2006;36:216-20.
21. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98.
22. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294:2203-9.
23. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-81.
24. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-25.
25. Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2005; Issue 3. Art. No.: CD001927.
26. Lip G Y, Lim HS. Atrial fibrillation and stroke prevention. Lancet Neurol 2007;6:981-93.
27. Desbiens NA. Deciding on anticoagulating the oldest old with atrial fibrillation: insights from cost-effectiveness analysis. J Am Geriatr Soc 2002;50:863-9.
28. Man-Son-Hing M, Laupacis A. Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation. Arch Intern Med 2002;162:541-50.
29. Gurwitz JH, Field TS, Radford MJ, Harrold LR, Becker R, Reed G, et al. The safety of warfarin therapy in the nursing home setting. Am J Med 2007;120:539-44.
30. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
31. Perera V, Bajorek B V, Matthews S, Hilmer SN. The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing 2009;38:156-62.
32. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16.
33. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000;109:87-94.
34. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-51.
35. Mamdani M, Juurlink DN, Kopp A, Naglie G, Austin PC, Laupacis A. Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study. BMJ 2004;328:1415-16.
36. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24.
37. Zuckerman IH, Langenberg P, Baumgarten M, Orwig D, Byrns PJ, Simoni-Wastila L, et al. Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults. Med Care 2006;44:722-30.
38. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009;85:86-8.
39. Laroche ML, Charmes J P, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007;63:177-86.
40. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007;370:185-91.
41. Field TS, Mazor KM, Briesacher B, Debellis KR, Gurwitz JH. Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc 2007;55:271-6.
42. Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323-8.
43. Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008;25:1021-31.
44. Treloar A, Philpot M, Beats B. Concealing medication in patients' food. Lancet 2001;357:62-4.
45. Bullock R. Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings. Curr Med Res Opin 2005;21:1-10.
46. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev 2006; Issue 1. Art. No.: CD003476.
47. Secker B. Labeling patient (in) competence: a feminist analysis of medicolegal discourse. J Soc Philos 1999;30:295-314.
48. Kluge EH. Ethical issues in geriatric medicine: a unique problematic. Health Care Anal 2002;10:379-90.
49. Davis MW, Le Couteur DG, Trim G, Buchanan J, Rubenach S, McLean AJ. Older people in hospital. Australas J Ageing 1999;18(suppl):S26-S31.
50. Guardianship Tribunal. Substitute consent. Balmain: Guardianship Tribunal; 2004. Available from .
51. Harris J. The age-indifference principle and equality. Camb Q Healthc Ethics 2005;14:93-9.